A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma

NCT00416273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: No intervention

Sponsor

Janssen-Cilag G.m.b.H